U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07672743) titled 'A Phase II Study of Radiation Therapy to Treat Refractory Breast Cancer' on Jan. 25.
Brief Summary: For locally advanced or recurrent metastatic breast cancer that is resistant to systemic therapy, radiotherapy (RT) may be considered as the preferred treatment option when the lesion is unresectable, or the patient is not suitable for surgery. This study aim to evelatuate the local control of radical dose RT or new RT technique (such as patially fractionated radiation therapy, SFRT) for the locally advanced or recurrent metastatic breast cancer.
Study Start Date: June 30
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Interv...